Antinociceptive and anti-inflammatory effects of N-acetylcysteine and verapamil in Wistar rats
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Background: Antinociceptive anti-inflammatory drugs have many adverse effects. The goal of this investigation is to study the probable anti-inflammatory and analgesic effects of verapamil and N-acetylcysteine (NAC) in experimental rats. Methods: Adult male Wistar rats were randomly divided into 4 groups in the antinociceptive study, each containing 6 rats; the normal control group, which received saline (1 mL/kg); the diclofenac group, which received diclofenac sodium (5 mg/kg); the NAC group, which received NAC (125 mg/kg); and the verapamil group, which received verapamil (8 mg/kg). In the anti-inflammatory study, 5 groups were used, the 4 previous groups with the addition of an edema control group, received saline and were subjected to formalin test. Hot plate latency time was recorded for antinociceptive evaluation. Paw edema thickness and biochemical parameters were recorded for anti-inflammatory evaluation. Results: Administration of NAC showed significant prolongation of hot plate latency time at 1 hour when compared to the control group while verapamil showed a significant prolongation of hot plate latency time at 1 and 2 hours when compared to the control group and NAC group values. Administration of NAC and verapamil significantly decreased paw edema thickness at 2, 4, and 8 hours when compared to edema control values. Regarding biochemical markers, NAC and verapamil significantly decreased serum nitric oxide synthase, C-reactive protein, and cyclooxygenase- 2 levels compared to the edema control value. In accordance, a marked improvement of histopathological findings was observed with both drugs. Conclusions: NAC and verapamil have antinociceptive and anti-inflammatory effects comparable to diclofenac sodium.
Abstract
Background: Antinociceptive anti-inflammatory drugs have many adverse effects. The goal of this investigation is to study the probable anti-inflammatory and analgesic effects of verapamil and N-acetylcysteine (NAC) in experimental rats. Methods: Adult male Wistar rats were randomly divided into 4 groups in the antinociceptive study, each containing 6 rats; the normal control group, which received saline (1 mL/kg); the diclofenac group, which received diclofenac sodium (5 mg/kg); the NAC group, which received NAC (125 mg/kg); and the verapamil group, which received verapamil (8 mg/kg). In the anti-inflammatory study, 5 groups were used, the 4 previous groups with the addition of an edema control group, received saline and were subjected to formalin test. Hot plate latency time was recorded for antinociceptive evaluation. Paw edema thickness and biochemical parameters were recorded for anti-inflammatory evaluation. Results: Administration of NAC showed significant prolongation of hot plate latency time at 1 hour when compared to the control group while verapamil showed a significant prolongation of hot plate latency time at 1 and 2 hours when compared to the control group and NAC group values. Administration of NAC and verapamil significantly decreased paw edema thickness at 2, 4, and 8 hours when compared to edema control values. Regarding biochemical markers, NAC and verapamil significantly decreased serum nitric oxide synthase, C-reactive protein, and cyclooxygenase- 2 levels compared to the edema control value. In accordance, a marked improvement of histopathological findings was observed with both drugs. Conclusions: NAC and verapamil have antinociceptive and anti-inflammatory effects comparable to diclofenac sodium.
참고문헌 (48)
- Swarup A, "A comparative study of efficacy of gabapentin in inflammation induced neuropathic animal pain models with conventional analgesic diclofenac", Int J Res Med Sci, 4, pp.1429~1432 (2016)
- Trevisan G, "TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes", macrophages and oxidative stress, 2016, pp.139, 1361~1377
- Hasanvand A, "The antinociceptive effects of rosuvastatin in chronic constriction injury model of male rats", Basic Clin Neurosci, 9, pp.251~260 (2018)
- Howard L Fields, "Pain free : modern drugs and neuropathic pain", J Korean Med Sci, 22, pp.360~367 (2002)
- McGettigan P, "Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk : an examination of sales and essential medicines lists in low-, middle-, and high-income countries", PLoS Med, 10, pp.e1001388~ (2013)
- Tardiolo G, "Overview on the effects of N-acetylcysteine in neurodegenerative diseases", Molecules, 23, pp.E3305~ (2018)
- Triggle DJ, "Calcium-channel drugs: structure-function relationships and selectivity of action", J Cardiovasc Pharmacol, 18(Suppl 10), pp.S1~S6 (1991)
- Hotchkiss RS, "Calcium antagonists inhibit oxidative burst and nitrite formation in lipopolysaccharide-stimulated rat peritoneal macrophages", Shock, 8, pp.170~178 (1997)
- Liu Y, "Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation", Neuropharmacology, 60, pp.373~380 (2011)
- Kalonia H, "Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats", Brain Res, 1372, pp.115~126 (2011)
- Eteraf-Oskouei T, "Anti-inflammatory and anti-angiogenesis effects of verapamil on rat air pouch inflammation model", Adv Pharm Bull, 7, pp.585~591 (2017)
- Zimmermann M, "Ethical guidelines for investigations of experimental pain in conscious animals", Pain, 16, pp.109~110 (1983)
- Yuan J, "A pharmacokinetic study of diclofenac sodium in rats", Biomed Rep, 7, pp.179~182 (2017)
- Horst A, "Effects of N-acetylcysteine on spinal cord oxidative stress biomarkers in rats with neuropathic pain", Braz J Med Biol Res, 50, pp.e6533~ (2017)
- Tamaddonfard E, "Role of opioid system in verapamil-induced antinociception in a rat model of orofacial pain", Vet Res Forum, 5, pp.49~54 (2014)
- Langerman L, "Hot plate versus tail flick : evaluation of acute tolerance to continuous morphine infusion in the rat model", J Pharmacol Toxicol Methods, 34, pp.23~27 (1995)
- Espejo EF, "Structure of the rat’s behaviour in the hot plate test", Behav Brain Res, 56, pp.171~176 (1993)
- Vittalrao AM, "Evaluation of antiinflammatory and analgesic activities of alcoholic extract of Kaempferia galanga in rats", Indian J Physiol Pharmacol, 55, pp.13~24 (2011)
- Yoon MH, "Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test", Anesthesiology, 99, pp.701~707 (2003)
- Van Herck H, "Orbital sinus blood sampling in rats as performed by different animal technicians : the influence of technique and expertise", Lab Anim, 32, pp.377~386 (1998)
- Yamamoto-Fukud T, "Effects of various decalcification protocols on detection of DNA strand breaks by terminal dUTP nick end labelling", Histochem J, 32, pp.697~702 (2000)
- Giglio CA, "Behavioral and physiological methods for early quantitative assessment of spinal cord injury and prognosis in rats", Braz J Med Biol Res, 39, pp.1613~1623 (2006)
- Horst A, "Effect of N-acetylcysteine on the spinal-cord glutathione system and nitric-oxide metabolites in rats with neuropathic pain", Neurosci Lett, 569, pp.163~168 (2014)
- Abdollahi M, "Potentiation by nitric oxide synthase inhibitor and calcium channel blocker of aspartame-induced antinociception in the mouse formalin test", Fundam Clin Pharmacol, 15, pp.117~123 (2001)
- 이일옥, "Effects of Different Concentrations of Formalin on Paw Edema and Pain Behaviors in Rats", Journal of Korean Medical Science, 17(1), pp.81~85 (2002), 대한의학회
- Damas J, "The inflammatory reaction induced by formalin in the rat paw", Naunyn Schmiedebergs Arch Pharmacol, 359, pp.220~227 (1999)
- Lasram MM, "Antioxidant and anti-inflammatory effects of N-acetylcysteine against malathion-induced liver damages and immunotoxicity in rats", Life Sci, 107, pp.50~58 (2014)
- Farshid AA, "Effects of histidine and N-acetylcysteine on diclofenac-induced anti-inflammatory response in acute inflammation in rats", Indian J Exp Biol, 48, pp.1136~1142 (2010)
- Martinez LL, "Influence of verapamil and diclofenac on leukocyte migration in rats", Hypertension, 34, pp.997~1001 (1999)
- Berk M, "The promise of N-acetylcysteine in neuropsychiatry", Trends Pharmacol Sci, 34, pp.167~177 (2013)
- Pireddu R, "Diclofenac acid nanocrystals as an effective strategy to reduce in vivo skin inflammation by improving dermal drug bioavailability", Colloids Surf B Biointerfaces, 143, pp.64~70 (2016)
- Messiha BA, "Protective effects of fish oil, allopurinol, and verapamil on hepatic ischemia-reperfusion injury in rats", J Nat Sci Biol Med, 6, pp.351~355 (2015)
- Ray SD, "Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen", FASEB J, 7, pp.453~463 (1993)
- Huang FM, "Protective effect of NAC on formaldehyde-containing-ZOE-based root-canalsealers-induced cyclooxygenase-2 expression and cytotoxicity in human osteoblastic cells", J Biomed Mater Res B Appl Biomater, 74, pp.768~773 (2005)
- Wang W, "Chronic calcium channel inhibitor verapamil antagonizes TNF-α-mediated inflammatory reaction and protects against inflammatory arthritis in mice", Inflammation, 39, pp.1624~1634 (2016)
- Kusama K, "Regulatory action of calcium ion on cyclic AMP-enhanced expression of implantation-related factors in human endometrial cells", PLoS One, 10, pp.e0132017~ (2015)
- Ferreira SH, "Bradykinin initiates cytokine-mediated inflammatory hyperalgesia", Br J Pharmacol, 110, pp.1227~1231 (1993)
- Pathak S, "N-Acetylcysteine attenuates tumor necrosis factor alpha levels in autoimmune inner ear disease patients", Immunol Res, 63, pp.236~245 (2015)
- Talasaz AH, "N-Acetylcysteine effects on transforming growth factor-β and tumor necrosis factor-α serum levels as profibrotic and inflammatory biomarkers in patients following ST-segment elevation myocardial infarction", Drugs R D, 13, pp.199~205 (2013)
- Park JH, "The antioxidant N-acetylcysteine inhibits inflammatory and apoptotic processes in human conjunctival epithelial cells in a high-glucose environment", Invest Ophthalmol Vis Sci, 56, pp.5614~5621 (2015)
- Li G, "Verapamil modulates LPS-induced cytokine production via inhibition of NF-kappa B activation in the liver", Inflamm Res, 55, pp.108~113 (2006)
- Guibas GV, "N-acetylcysteine exerts therapeutic action in a rat model of allergic rhinitis", Int Forum Allergy Rhinol, 3, pp.543~549 (2013)
- Bergamini S, "N-acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase", Nitric Oxide, 5, pp.349~360 (2001)
- Saddadi F, "The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis", Saudi J Kidney Dis Transpl, 25, pp.66~72 (2014)
- Nascimento MM, "Effect of oral N-acetylcysteine treatment on plasma inf lammatory and oxidative stress markers in peritoneal dialysis patients : a placebo-controlled study", Perit Dial Int, 30, pp.336~342 (2010)
- Pepys MB, "C-reactive protein : a critical update", J Clin Invest, 111, pp.1805~1812 (2003)
- Bakris GL, "Implications of albuminuria on kidney disease progression", J Clin Hypertens (Greenwich), 6(11 Suppl 3), pp.18~22 (2004)
- Bleier BS, "Verapamil modulates interleukin-5 and interleukin-6 secretion in organotypic human sinonasal polyp explants", Int Forum Allergy Rhinol, 5, pp.10~13 (2015)